Search for: "Johnson v. Board of Appeals and Review"
Results 221 - 240
of 537
Sorted by Relevance
|
Sort by Date
29 Mar 2010, 6:58 am
(Business IP and Intangible Asset Blog) US Patents – Decisions Split Federal Circuit panel finds preamble language not limiting: Marrin v Griffin (GRAY on Claims) (Inventive Step) District Court E D Texas: Inequitable conduct expert could not testify as to materiality absent qualification as a person skilled in the art: Advanced Technology Incubator, Inc v Sharp Corporation et al (Docket Report) District Court N D California: Intracompany patent transfer strikes again:… [read post]
13 Jun 2022, 1:01 am
Kennedy appointed Marshall to the United States Court of Appeals for the Second Circuit. [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd:… [read post]
3 Dec 2015, 1:26 pm
On appeal, an NLRB panel ruled in a 2-1 decision: Applying the Board’s decisions in D.R. [read post]
19 Sep 2011, 3:17 am
Johnson & Johnson (Chicago IP Litigation) Minemyer – Court refuses ‘back door’ attempt at claim construction: Minemyer v. [read post]
19 Sep 2008, 6:00 pm
: (IPRoo), Australia's National Innovation Review report: Ventureaustralia - venture capital and the value of IP? [read post]
24 May 2010, 7:42 am
The appeal in AT&T Mobility v. [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy:… [read post]
27 Feb 2015, 6:15 am
Johnson, 13-10288 (second relist). [read post]
18 Feb 2015, 1:30 pm
Johnson; (2) whether a conviction aided by the prosecution's failure to produce evidence that contradicted its theory and showed that the evidence it did rely upon and the resulting jury arguments were false violates the Due Process Clauses of the Fifth and Fourteenth Amendments under this Court's Brady v. [read post]
20 Jun 2014, 10:14 am
John Elwood reviews Monday’s relisted cases. [read post]
13 Jan 2016, 9:29 am
See Wyers v. [read post]
6 Oct 2016, 2:33 pm
CLEMENS, Appellant, v. [read post]
25 Feb 2010, 12:14 am
Alan Johnson was “a lightweight”. [read post]
7 Sep 2017, 10:30 am
The government appealed that decision by Judge Alvin Hellerstein of the Southern District of New York. [read post]
3 Mar 2009, 12:27 am
COURT OF APPEALS, SECOND CIRCUITCriminal PracticeApplication Note Clarified Scope of Guidelines Increase; Ex Post Facto Clause Not Implicated United States, appellee v. [read post]
22 Dec 2007, 7:31 am
Figiri Shkulaku-Purballori petitions this Court for review of the decision by the Board of Immigration Appeals denying his request for asylum, or, in the alternative, Convention Against Torture relief or withholding of removal. [read post]
7 Jan 2015, 10:52 am
At its Conference on January 9, 2015, the Court will consider petitions seeking review of issues such as state bans on same-sex marriage, proof of intent in a constructive discharge case, personal jurisdiction to award a no-contact order, and the presumption of judicial vindictiveness under North Carolina v. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
12 Dec 2014, 7:11 am
JR 38, Re Judicial Review, heard 6 November 2014. [read post]
